We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Dosing Study of Ranibizumab for Diabetic Retinal and Macular Edema

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01476449
Recruitment Status : Completed
First Posted : November 22, 2011
Last Update Posted : October 5, 2016
Genentech, Inc.
Information provided by (Responsible Party):
Retina Vitreous Associates of Florida

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : September 2016
  Study Completion Date : September 2016